Rare Disease Diagnoses That Started With Something Else Entirely

Why Rare Diseases Are So Often Found by Accident

A rare disease in the United States is defined as one affecting fewer than 200,000 people nationally. There are over 7,000 known rare diseases, and most clinicians will see only a handful in their entire career. That math creates a problem. The classic presentations of rare diseases are not in the working memory of most primary care doctors, so patients often spend years cycling through specialists before someone connects the dots. The average rare disease diagnosis takes 5 to 7 years and several misdiagnoses, according to long-running surveys from the National Organization for Rare Disorders.

Routine medical care occasionally short-circuits the long road. A scan ordered for one reason picks up something else. A surgery exposes tissue that a pathologist recognizes as unusual. A specialist outside the patient's usual care team spots a finding that the rest of the team missed. These are called incidental findings, and for several specific rare diseases they have become recognized diagnostic pathways with published guidelines. The eight case patterns below are the most established ones in current literature.

Bilateral carpal tunnel syndrome (numbness and tingling in both hands from a compressed median nerve) is one of the earliest warning signs of transthyretin amyloidosis (ATTR), a rare disease in which a misfolded transport protein deposits in the heart, nerves, and other tissues. The hand symptoms typically appear 5 to 10 years before the cardiac involvement becomes clinically obvious (Sperry et al., Journal of the American College of Cardiology, 2018).

Because the amyloid protein deposits in the carpal tunnel itself before reaching the heart, a small piece of tenosynovium (the soft tissue around the median nerve) can be biopsied during routine carpal tunnel release surgery and tested for amyloid. A 2022 JACC study screened patients 5 to 15 years after bilateral carpal tunnel surgery and found cardiac amyloidosis in 4.8% of them, all with wild-type ATTR (Westin et al., JACC, 2022). Several major centers now perform routine tenosynovium biopsy during carpal tunnel release in older patients, particularly older men, because catching ATTR early gives access to disease-modifying therapy for the heart (such as tafamidis or vutrisiran) before significant cardiac damage occurs.

If you had bilateral carpal tunnel surgery in middle age or later, especially without an obvious cause like repetitive strain, raising the possibility of amyloidosis with your cardiologist or a hand surgeon familiar with the link is a reasonable conversation. The screening is a simple echocardiogram and, in some centers, a pyrophosphate (PYP) scan.

Wilson Disease Caught by a Routine Eye Exam

Wilson disease is a rare inherited disorder of copper metabolism that affects roughly 1 in 30,000 people. Copper builds up in the liver, brain, and eyes when the ATP7B gene that normally clears it is broken. Untreated, the disease causes liver failure and severe neurological disability. With treatment (zinc, penicillamine, trientine, or the newer agent bis-choline tetrathiomolybdate), most patients have normal or near-normal lifespans.

The eye finding is the diagnostic anchor. Excess copper deposits in the Descemet membrane of the cornea, creating a brownish or greenish ring at the edge of the iris called a Kayser-Fleischer ring. Approximately 95% of Wilson patients who present with neurological symptoms have these rings (StatPearls / Kayser-Fleischer Ring review). The rings are usually invisible to the naked eye in early disease but show up clearly under slit-lamp examination, which is the standard tool of every optometrist and ophthalmologist. Several published case reports describe young patients whose first Wilson disease clue came from a routine vision check or contact lens fitting.

If you have unexplained liver enzyme elevations, tremor, dystonia, or psychiatric symptoms in your teens or twenties, the next step is a slit-lamp exam plus a ceruloplasmin and 24-hour urine copper test. Our Wilson disease page covers the diagnostic workup and current trial options.

Pheochromocytoma Discovered as an Adrenal Incidentaloma on CT

Adrenal incidentalomas are masses on the adrenal glands found by accident during CT or MRI imaging done for something unrelated, such as kidney stones, back pain, or trauma. They show up in 1% to 8.7% of all abdominal imaging studies. Most adrenal incidentalomas are benign adenomas, but roughly 7% turn out to be pheochromocytomas, rare catecholamine-secreting tumors that can cause severe hypertension, palpitations, and (in unrecognized cases) sudden cardiac death (Buitenwerf et al., Journal of Clinical Endocrinology and Metabolism, 2019).

Up to 30% of pheochromocytomas are diagnosed because someone got a scan for a different problem and the radiologist flagged the adrenal mass. About 25% of pheo patients have no classic symptoms at all, which means the imaging finding is sometimes the first indication that anything is wrong. The standard workup after an adrenal incidentaloma includes plasma free metanephrines or 24-hour urine fractionated metanephrines specifically to rule out pheochromocytoma before any surgical intervention, because operating on an undiagnosed pheo can trigger a hypertensive crisis.

If a CT report mentions an adrenal nodule or incidentaloma in your medical record, the follow-up labs and an endocrinology referral are worth pursuing even if you feel fine, because both pheochromocytoma and its hereditary forms (von Hippel-Lindau, MEN2, neurofibromatosis, succinate dehydrogenase mutations) are treatable but dangerous when missed.

Fabry Disease Found After a Young-Adult Stroke With No Other Explanation

Fabry disease is a rare X-linked lysosomal storage disorder caused by mutations in the GLA gene, leading to deposits of globotriaosylceramide in blood vessels, kidneys, heart, and the nervous system. Estimated prevalence is roughly 1 in 40,000 to 1 in 117,000, though many cases are undiagnosed. The disease causes early small-vessel disease in the brain, and stroke in young adults with no other risk factors (no diabetes, hypertension, smoking, atrial fibrillation, or clotting disorders) is one of the recognized presentations.

Cryptogenic ischemic stroke screening studies have found Fabry disease in 0.3% to nearly 5% of young patients with otherwise unexplained strokes, with prevalence varying by population and screening criteria. A landmark German study of 721 young stroke patients reported Fabry in 4.9% of males and 2.4% of females (Rolfs et al., Stroke, 2005). Subsequent studies in other populations have found lower rates, but the consensus is that targeted screening, especially in young males with systemic clues like cornea verticillata (whorl-like corneal deposits) or unexplained kidney involvement, has clear value.

Fabry diagnosis is a simple blood test for alpha-galactosidase enzyme activity in males or genetic testing in females. Enzyme replacement therapy with agalsidase beta or agalsidase alfa, plus oral chaperone therapy with migalastat for amenable mutations, can slow disease progression substantially when started early. A young adult with cryptogenic stroke has a defensible reason to ask their neurologist whether a Fabry workup makes sense for them.

Hereditary Hemorrhagic Telangiectasia Found by Chronic Nosebleeds Plus a Chest CT

Hereditary hemorrhagic telangiectasia (HHT), also called Osler-Weber-Rendu syndrome, is a rare inherited blood vessel disorder affecting about 1 in 5,000 people. Patients have abnormal blood vessels (telangiectasias and arteriovenous malformations, or AVMs) that can rupture in the nose, gut, lungs, liver, and brain. About 90% of HHT patients have recurrent nosebleeds, and many of them spend years assuming this is just unfortunate genetics rather than a treatable systemic disease.

The diagnostic clue often comes from imaging done for an unrelated reason. Approximately 30% to 50% of HHT patients have pulmonary AVMs, which appear on chest CT as nodules or vascular structures and are often picked up incidentally on scans done for cough, chest pain, or routine cancer screening (Cleveland Clinic HHT overview; GeneReviews HHT). Brain AVMs and liver AVMs are similarly often discovered on imaging done for headache or abdominal symptoms. Pulmonary AVMs are silent until something catastrophic happens, like a stroke from a paradoxical embolus or a sudden lung hemorrhage, so finding them early matters.

If you or a family member has chronic nosebleeds and a relative with vascular events, telangiectasias visible on lips or fingertips, or a known AVM anywhere, an HHT workup at a designated HHT Center of Excellence is the right call. Embolization of pulmonary AVMs is a routine outpatient procedure that prevents future strokes and brain abscesses.

Hereditary Angioedema Found After Years of Misdiagnosed Abdominal Pain

Hereditary angioedema (HAE) is a rare genetic disease causing recurrent swelling attacks of the face, throat, hands, feet, and (most often) the abdomen. Estimated prevalence is roughly 1 in 50,000. The attacks come from a missing or dysfunctional C1 esterase inhibitor protein, which leads to overproduction of bradykinin and tissue swelling. Throat attacks can be fatal if untreated.

Abdominal attacks are the diagnostic trap. HAE patients describe severe abdominal pain, vomiting, and sometimes bowel wall edema visible on imaging. Without a family history or known HAE, the picture looks like appendicitis, gastroenteritis, cholecystitis, or pancreatitis. A meta-analysis of HAE patient experience found 10.4% are misdiagnosed as appendicitis and 24.7% undergo unnecessary appendectomy or other exploratory abdominal surgery, with an average diagnostic delay of 8.3 years (multiple international HAE patient surveys). The diagnostic clue that often finally cracks it is the fact that the attacks recur, the patient's airways or face have also swollen at some point, the swelling does not respond to epinephrine or antihistamines, and a family member has had similar episodes.

Diagnosis is a blood test for C4 (low in HAE) plus C1 inhibitor level and function. Approved treatments include on-demand therapies (icatibant, ecallantide, plasma-derived or recombinant C1 inhibitor) and prophylactic therapies (lanadelumab, berotralstat, plasma-derived C1 inhibitor). Patients with recurrent unexplained abdominal pain, especially with family history of similar attacks, have a defensible reason to ask for C4 testing.

Acromegaly Noticed by a Dentist or Through Sleep Apnea Workup

Acromegaly is a rare disease caused by a pituitary tumor secreting growth hormone in adults. Bones thicken, soft tissues enlarge, organs grow, and the face changes shape gradually over years. Annual incidence is roughly 3 to 4 per million. The changes are slow, which is why patients rarely notice them themselves. Family and old photographs sometimes capture the transformation more clearly than the patient does.

Several incidental routes have caught acromegaly earlier than the patient's own concern would have. Dentists notice when teeth start spreading apart because the jaw is growing, or when the bite changes and crowns no longer fit. Sleep specialists pick up the link when severe obstructive sleep apnea (driven by enlarged tongue and pharyngeal tissues) does not respond well to weight loss or standard CPAP titration, prompting a referral for an MRI that finds a pituitary tumor. Anesthesiologists have caught acromegaly when an unexpectedly difficult intubation revealed an enlarged tongue and thickened airway. Cardiologists have caught it when echocardiograms in a younger-than-expected patient showed unexplained cardiomyopathy.

Diagnosis is an IGF-1 blood test followed by an oral glucose tolerance test for growth hormone suppression and an MRI of the pituitary. Surgery, somatostatin analogs (octreotide, lanreotide, pasireotide), the GH receptor antagonist pegvisomant, and radiation therapy each have a role. Our acromegaly page covers current trial options and treatment approaches.

Charcot-Marie-Tooth Disease Diagnosed by a Foot Specialist

Charcot-Marie-Tooth disease (CMT) is a group of inherited peripheral nerve disorders affecting about 1 in 2,500 people, making it the most common inherited neurological condition. Patients have progressive weakness of the lower legs and hands, with characteristic foot deformities that often appear in childhood or early adulthood. CMT is genetically heterogeneous, with more than 100 known causal genes and multiple subtypes (CMT1A, CMT1B, CMT2A, CMTX, CMT4, and others).

The foot specialist (podiatrist or orthopedic surgeon) is often the first to see the diagnostic clue. Pes cavus (a high-arched foot) and hammertoes are classic CMT signs and frequently bring patients in for shoe fittings, orthotics, or surgical correction. A specialist who recognizes the pattern asks about distal leg weakness, foot drop, family history, and ankle-jerk reflexes. Nerve conduction studies and genetic testing confirm the diagnosis. Several recent case series document patients who arrived for what they thought was a simple bunion or arch problem and left with a hereditary neurological disease diagnosis.

Although no FDA-approved disease-modifying therapy exists yet for most CMT subtypes, the diagnosis matters for genetic counseling, prognosis, occupational planning, anesthesia safety (some agents are dangerous in CMT), and access to clinical trials. Several pipeline drugs (PXT3003, DTx-1252, EN001) are now in active trials for specific subtypes. Our Charcot-Marie-Tooth disease page covers the current trial pipeline by subtype.

What to Do If One of These Patterns Sounds Like You

The patterns above are documented, but they are also rare. Most carpal tunnel surgeries do not lead to an amyloidosis diagnosis. Most adrenal incidentalomas are benign adenomas, not pheochromocytomas. Most chronic nosebleeds are not HHT. The point of recognizing these patterns is not to worry about every possible diagnosis. The point is to know what the red flags are, so that if multiple flags fit your situation, you have a defensible reason to ask for the specific workup.

Three practical steps if any of these patterns rings a bell. First, write down your full timeline, including family history, all symptoms you have noticed over the past 5 to 10 years, and any imaging or biopsy reports that mentioned unexpected findings. Second, request the specific specialty referral that matches the pattern rather than another general primary care visit. A hand surgeon for bilateral carpal tunnel, a clinical geneticist for family cancer patterns, an HHT Center of Excellence for nosebleeds plus vascular events. Third, ask for the specific diagnostic test rather than describing your symptoms in general terms, because the right test (C4 level, IGF-1, slit-lamp exam, alpha-galactosidase activity) is often not part of the standard workup unless someone names it explicitly.

Patient advocacy organizations are the fastest way to find a specialist who recognizes the pattern. The Wilson Disease Association, the National HHT Foundation, the US HAE Association, the Charcot-Marie-Tooth Association, the Acromegaly Community, the Amyloidosis Foundation, and the Fabry Support and Information Group each maintain referral networks to clinicians who see the disease often enough to catch it the first time. The National Organization for Rare Disorders (NORD) maintains a master directory of disease-specific resources that is worth bookmarking.

Frequently Asked Questions About Accidental Rare Disease Diagnoses

Find a Specialist or a Trial for a Specific Rare Disease

If any of the patterns in this post described your situation, the next step is a conversation with a specialist who treats the disease in question regularly. The diagnostic delay for most rare diseases comes from clinicians who have not seen the pattern before, not from the absence of tests or treatments. Disease-specific expertise can collapse years off a diagnostic journey.

Trial Friend lists active trials for many of the conditions in this post in patient-friendly language. Browse our disease pages for Wilson disease, Charcot-Marie-Tooth disease, acromegaly, hereditary angioedema, or any of the others mentioned above. If you do not have a diagnosis yet but suspect one of these conditions, the patient advocacy organizations linked in the section above are the right starting point. The path to an accurate diagnosis is often shorter than patients fear, once it reaches someone who knows what they are looking at.